Biotech · Private company · Arlington, MA, US

Neurodex Inc

Track this companyFree. Adds Neurodex Inc to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards3

Development of a Blood-based Test for Identifying Synucleinopathy in Patients with DementiaFiscal year 2025 · $518.2KNIH RePORTER 5R44NS130864-04 · fetched Nov 12, 2026
Blood-based Biomarker for Characterizing Progression and Therapeutic Response in Amyotrophic Lateral SclerosisFiscal year 2024 · $2.1MNIH RePORTER 1R44NS137901-01A1 · fetched Nov 12, 2026
Development of a Blood-based Test for Identifying Synucleinopathy in Patients with DementiaFiscal year 2024 · $942.2KNIH RePORTER 5R44NS130864-03 · fetched Nov 12, 2026